David B. Sacks, MB ChB

David B. Sacks, MB ChB, FRCPath
Chief, Clinical Chemistry Service
Department of Laboratory Medicine

Academic Degrees
MB ChB, University of Cape Town, South Africa

Email: sacksdb@mail.nih.gov

Phone: 301-496-3386

Back to Senior Staff Directory

NIH Clinical Center Senior Staff

David B. Sacks, MB ChB, FRCPath


David B. Sacks received his medical training at the University of Cape Town, South Africa. He completed residencies in Internal Medicine at Georgetown University affiliated hospitals in Washington, D.C. and in Clinical Pathology at Washington University School of Medicine in St. Louis and is board certified in both disciplines. After completing fellowship training in Clinical Chemistry at Washington University School of Medicine, he joined the Department of Pathology at Harvard Medical School and Brigham and Women's Hospital, where he was both Medical Director of Clinical Chemistry and Director of the Clinical Pathology Training Program. He joined the NIH as Chief of Clinical Chemistry in 2011.

The scientific work in his research laboratory is in the general area of intracellular signal transduction, with a focus on calcium and calmodulin signaling. His research was funded for over 20 years by grants from the National Institutes of Health, the American Diabetes Association, the Diabetes Action Research and Education Foundation, the Susan G. Komen Breast Cancer Foundation, the U.S. Army and the Burroughs Wellcome Fund.

Dr. Sacks's primary clinical focus is in diabetes mellitus, with an emphasis on the interface between the clinical laboratory and patient care. In this endeavor, he has worked closely with the American Diabetes Association. He is Chair of the National Glycohemoglobin Standardization Program (NGSP) steering committee. He was Director of the Young Investigator Program of the Academy of Clinical Laboratory Physicians and Scientists (ACLPS) from 1995-2001 and later served as President of ACLPS. In addition, he serves on or chairs several other national and international committees. He was elected a Fellow of the Royal College of Pathologists in 1998.

Dr. Sacks has published more than 180 articles in scientific journals. He has been a member of the editorial board of Clinical Chemistry since 1995 and is currently an Associate Editor of the journal. In addition, he has served on several other editorial boards, including The Journal of Biological Chemistry, The American Journal of Pathology and The American Journal of Clinical Pathology and is a member of the editorial advisory panel of The Biochemical Journal.

Selected Honors and Awards

Outstanding Contributions in Education, American Association for Clinical Chemistry, 2012; Distinguished Scientist Award, National Academy of Clinical Biochemistry, 2009; Gerald T. Evans Award, Academy of Clinical Laboratory Physicians and Scientists, 2008; Visiting Professor, South African Association of Clinical Biochemists, 2007; Transatlantic Award Lecture, The Association for Clinical Biochemistry UK, 2007; Norman P. Kubasik Lectureship Award, American Association for Clinical Chemistry, Upstate New York Section, 2006; Outstanding Contributions to Clinical Chemistry in a Selected Area of Research, American Association for Clinical Chemistry, 2005; Visiting Professor, Royal College of Pathologists of Australasia, 2003; Lilian B. Ladenson and Oree M. Caroll Visiting Professor, Washington University School of Medicine, 1998.

Selected Publications


Erdemir HH, Li Z, Sacks DB. IQGAP1 binds to estrogen receptor-α and modulates its function. J Biol Chem 2014; 289:9100-9112.

Choi S, Thapa N, Hedman AC, Li Z, Sacks DB, Anderson RA. IQGAP1 is a novel phosphatidylinositol 4,5 bisphosphate effector in regulation of directional cell migration. EMBO J 2013; 32:2617-2630.

Zhang Y, Li Z, Sacks DB, Ames JB. Structural basis for Ca2+-induced activation and dimerization of estrogen receptor α by calmodulin. J Biol Chem 2012; 287:9336-9344.
[Journal of Biological Chemistry Paper of the Week] [Recommended by the Faculty of 1000]

White CD, Li Z, Dillon DA, Sacks DB. IQGAP1 binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance. J Biol Chem 2011; 286:29734-29747.
[Recommended by the Faculty of 1000]

Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan, DM. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011; 57:793-798.
[Published concurrently in Diabetes Care 2011; 34:1419-1423.]

McNulty DE, Li Z, White CD, Sacks DB, Annan RS. MAP kinase scaffold IQGAP1 binds the EGF receptor and modulates its activation. J Biol Chem 2011; 286:15010-15021.

Brown MD, Bry L, Li Z, Sacks DB. Actin pedestal formation by EPEC is regulated by IQGAP1, calcium and calmodulin. J Biol Chem 2008; 283: 35212-35222.

Jadeski L, Mataraza JM, Jeong HW, Li Z, Sacks DB. IQGAP1 stimulates proliferation and enhances tumourigenesis of human breast epithelial cells. J Biol Chem 2008; 283:1008-1017.

Brown MD, Bry L, Li Z, Sacks DB. IQGAP1 regulates Salmonella invasion through interactions with actin, Rac1 and Cdc42. J Biol Chem 2007; 282:30265-30272.

Jeong HW, Li Z, Brown MD, Sacks DB. IQGAP1 binds Rap1 and modulates its activity. J Biol Chem 2007; 282:20752-20762.

Ren JG, Li Z, Sacks DB. IQGAP1 modulates activation of B-Raf. Proc Natl Acad Sci USA 2007; 104:10465-10469.

Li L, Li Z, Howley PM, Sacks DB. E6AP and calmodulin reciprocally regulate estrogen receptor stability. J Biol Chem 2006; 281:1978-1985.

Roy M, Li Z, Sacks DB. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol Cell Biol 2005; 25:7940-7952.

Li Z, McNulty DE, Marler KJM, Lim L, Hall C, Annan RS, Sacks DB. IQGAP1 promotes neurite outgrowth in a phosphorylation-dependent manner. J Biol Chem 2005; 280:13871-13878.


Smith JM, Hedman AC, Sacks DB. IQGAPs choreograph cellular signaling from the membrane to the nucleus [Review]. Trends Cell Biol 2015, in the press.

Sacks DB, John WG. Interpretation of hemoglobin A1c values. JAMA 2014; 311:2271-2272.

Sacks DB. Measurement of hemoglobin A1c: A new twist on the path to harmony [Review]. Diabetes Care 2012; 35:2674-2680.

Sacks DB. Diabetes mellitus. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 5th ed. St. Louis: Elsevier Saunders, 2012. p. 1415-1456.

Kim H, White CD, Sacks DB. IQGAP1 in microbial pathogenesis: Targeting the actin cytoskeleton [Review]. FEBS Lett 2011; 585:723-729.

Sacks DB. A1c versus glucose testing: A comparison [Review]. Diabetes Care 2011; 518-523.

Little RR, Rohlfing CL, Sacks DB. Status of HbA1c measurement and goals for improvement: From chaos to order for improving diabetes care [Review]. Clin Chem 2011; 57:204-214.

Sacks DB. Intensive glucose control in the ICU: Is SUGAR NICE? Nat Rev Endocrinol 2009; 5:473-474.

Scott MG, Bruns DE, Boyd JC, Sacks DB. Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem 2009; 55:18-20.

Brown MD, Sacks DB. IQGAP1 in cellular signalling: bridging the GAP [Review]. Trends Cell Biol 2006; 16:242-249.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 07/06/2017

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at http://www.cc.nih.gov/disclaimers.html